[HTML][HTML] Challenges in combining immunotherapy with radiotherapy in recurrent/metastatic head and neck cancer

G Plavc, T Jesenko, M Oražem, P Strojan - Cancers, 2020 - mdpi.com
Simple Summary Immunotherapy offers new hope for patients with recurrent or metastatic
head and neck cancer. However, only 20% of patients respond to this treatment. Combining …

Economic and social impacts of COVID-19 and public health measures: results from an anonymous online survey in Thailand, Malaysia, the UK, Italy and Slovenia

…, PK Cheah, P Peerawaranun, M Silan, M Orazem… - BMJ open, 2021 - bmjopen.bmj.com
Objectives To understand the impact of COVID-19 and public health measures on different
social groups, we conducted a mixed-methods study in five countries (‘SEBCOV—social, …

Telemedicine in radiation oncology post–COVID-19 pandemic: there is no turning Back

M Orazem, I Oblak, T Spanic, I Ratosa - International Journal of Radiation …, 2020 - Elsevier
Purpose We aimed to assess patients’ and physicians’ perspectives on wider implementation
of telemedicine in radiation oncology practice, disrupted by the novel coronavirus disease …

Cyclin-dependent kinase 4/6 inhibitors combined with radiotherapy for patients with metastatic breast cancer

I Ratosa, M Orazem, E Scoccimarro, M Steinacher… - Clinical Breast …, 2020 - Elsevier
Background The cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) represent the standard
treatment for hormone receptor–positive, human epidermal growth factor receptor 2–negative …

[HTML][HTML] Flow cytometric determination of actin polymerization in peripheral blood leukocytes effectively discriminate patients with homozygous mutation in ARPC1B …

AN Kopitar, G Markelj, M Oražem, Š Blazina… - Frontiers in …, 2019 - frontiersin.org
Actin nucleators initiate formation of actin filaments. Among them, the Arp2/3 complex has
the ability to form branched actin networks. This complex is regulated by members of the …

Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer

L Visani, L Livi, I Ratosa, M Orazem, D Ribnikar… - Radiotherapy and …, 2022 - Elsevier
Purpose Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) currently represent the standard
of care for the initial treatment of patients with metastatic hormone receptor-positive/human …

Notes on the development of the Slovenian ethical recommendations for decision-making on treatment and palliative care of patients at the end of life in intensive care …

S Grosek, M Orazem, U Groselj - Pediatric Critical Care Medicine, 2018 - journals.lww.com
Objectives: To describe the process of development of “Slovenian Ethical Recommendations
for Decision-Making on Treatment and Palliative Care of Patients at the End of Life in …

[HTML][HTML] Experiences of Slovene ICU physicians with end-of-life decision making: a nation-wide survey

U Groselj, M Orazem, M Kanic, G Vidmar… - … Medical Journal of …, 2014 - ncbi.nlm.nih.gov
Background Advances in intensive care medicine have enormously improved ability to
successfully treat seriously ill patients. However, intensive treatment and prolongation of life is not …

Etične dileme ob koncu življenja v intenzivni medicini

Š Grosek, U Grošelj, M Oražem… - Slovenian Medical Journal, 2013 - vestnik.szd.si
Sustaining vital functions in critically ill in the ICU frequently allows prolongation of patient’s
life even in circumstances where the treatment has lost its medical rationale and/or there is …

Attitudes of S lovene paediatricians to end‐of‐life care

S Grosek, M Orazem, M Kanic… - Journal of Paediatrics …, 2016 - Wiley Online Library
Aims The aims of this study were to assess the attitudes of S lovene paediatricians to aspects
of end‐of‐life ( EOL ) care and compare these attitudes between paediatric intensivists, …